768 
tracts entered into by the Secretary with respect to 
such a domestic production capability. 
(6) Any critical active pharmaceutical ingredi-
ents that are under consideration by the Secretary 
for future domestic production as of the date of the 
briefing. 
(7) The plan of the Secretary regarding the fu-
ture use of domestic production capability for critical 
active pharmaceutical ingredients. 
SEC. 746. BRIEFING ON ANOMALOUS HEALTH INCIDENTS 
INVOLVING 
MEMBERS 
OF 
THE 
ARMED 
FORCES. 
(a) BRIEFING.—Not later than March 1, 2022, the 
Secretary of Defense shall provide to the appropriate con-
gressional committees a briefing on anomalous health inci-
dents affecting members of the Armed Forces and civilian 
employees of the Department of Defense, any ongoing ef-
forts carried out by the Secretary to protect such members 
and employees from the effects of anomalous health inci-
dents, and the extent and nature of engagement by the 
Secretary with the heads of other Federal departments 
and agencies regarding anomalous health incidents affect-
ing the employees of such other departments and agencies. 
(b) MATTERS.—The briefing provided under sub-
section (a) shall include, at a minimum, the following:
769 
(1) Information on cases of confirmed or sus-
pected anomalous health incidents affecting mem-
bers of the Armed Forces or civilian employees of 
the Department. 
(2) An update on the strategy of the Depart-
ment to protect such members and employees from 
the effects of anomalous health incidents, including 
any efforts carried out by the Secretary to ensure 
that— 
(A) suspected anomalous health incidents 
are promptly reported; and 
(B) victims of anomalous health incidents 
are provided immediate and long-term medical 
treatment. 
(3) The current efforts of the Department to 
contribute to the overall approach of the U.S. Gov-
ernment to address, prevent, and respond to, anoma-
lous health incidents, including such contributed ef-
forts of the Department to defend against anoma-
lous health incident attacks against personnel of the 
U.S. Government and United States citizens. 
(4) The current efforts of the Department to 
prepare members of the Armed Forces and civilian 
employees of the Department for the effects of
770 
anomalous health incidents, including prior to de-
ployment. 
(5) Recommendations on how to improve the 
identification and reporting of anomalous health in-
cidents affecting such members and employees, in-
cluding a recommendation on whether to conduct a 
health assessment prior to the deployment of such 
members or employees if the prospective deployment 
is to an embassy of the United States (or to another 
location that the Secretary determines may present 
a heightened risk of anomalous health incidents), to 
establish a medical baseline against which medical 
data of the member or employee may be compared 
following a suspected anomalous health incident. 
(6) An identification by the Secretary of a sen-
ior official of the Department who has been des-
ignated by the Secretary as the official with prin-
cipal responsibility for leading the efforts of the De-
partment regarding anomalous health incidents (and 
related issues within the Department) and for co-
ordinating with the heads of other Federal depart-
ments and agencies regarding such incidents and re-
lated issues. 
(c) SENATE CONFIRMATION OF RESPONSIBLE INDI-
VIDUAL.—If the designated senior official identified pur-
771 
suant to subsection (b)(6) has not been appointed by and 
with the advice and consent of the Senate, the Secretary 
shall ensure that the principal responsibility for the ac-
tions specified in such subsection is transferred to a senior 
official of the Department who has been so appointed. 
(d) APPROPRIATE
CONGRESSIONAL
COMMITTEES 
DEFINED.—In this section, the term ‘‘appropriate con-
gressional committees’’ means— 
(1) the Committee on Armed Services, the 
Committee on Oversight and Reform, and the Com-
mittee on Transportation and Infrastructure of the 
House of Representatives; and 
(2) the Committee on Armed Services, the 
Committee on Homeland Security and Governmental 
Affairs, and the Committee on Commerce, Science, 
and Transportation of the Senate. 
SEC. 747. SENSE OF CONGRESS ON NATIONAL WARRIOR 
CALL DAY. 
(a) FINDINGS.—Congress finds the following: 
(1) Establishing an annual ‘‘National Warrior 
Call Day’’ will draw attention to those members of 
the Armed Forces whose connection to one another 
is key to our veterans and first responders who may 
be dangerously disconnected from family, friends, 
and support systems.
772 
(2) The number of suicides of members of the 
Armed Forces serving on active duty increased to 
377 in 2020, a figure up from 348 the previous 
year. 
(3) The epidemic of veteran suicide has steadily 
increased since 2014 with 6,435 veterans taking 
their own lives in 2018. 
(4) After adjusting for sex and age, the rate of 
veteran suicide in 2018 was 27.5 per 100,000 indi-
viduals, higher than the rate among all United 
States adults at 18.3. 
(5) More veterans have died by suicide in the 
last 10 years than members of the Armed Forces 
who died from combat in Vietnam. 
(6) Roughly two-thirds of these veterans who 
take their own lives have had no contact with the 
Department of Veterans Affairs. 
(7) The COVID–19 pandemic has only in-
creased isolation and disconnection, further exacer-
bating mental and physical ailments such as post- 
traumatic stress disorder and traumatic brain in-
jury. 
(8) The Centers for Disease Control and Pre-
vention note that law enforcement officers and fire-
fighters are more likely to die by suicide than in the
773 
line of duty, and emergency medical services pro-
viders are 1.39 times more likely to die by suicide 
than members of the general public. 
(9) Invisible wounds linked to an underlying 
and undiagnosed traumatic brain injury can mirror 
many mental health conditions, a problem that can 
be addressed through connections to members of the 
Armed Forces and veterans who can better identify 
and address these wounds. 
(10) Urgent research is needed to highlight the 
connection between traumatic brain injury as a root 
cause of invisible wounds and suicide by members of 
the Armed Forces and veterans. 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that Congress— 
(1) supports the designation of a ‘‘National 
Warrior Call Day’’; 
(2) encourages all Americans, especially mem-
bers of the Armed Forces serving on active duty and 
veterans, to call up a warrior, have an honest con-
versation, and connect them with support, under-
standing that making a warrior call could save a life; 
and 
(3) implores all Americans to recommit them-
selves to engaging with members of the Armed
774 
Forces through ‘‘National Warrior Call Day’’ and 
constructive efforts that result in solutions and 
treatment for the invisible scars they carry. 
SEC. 748. MANDATORY TRAINING ON HEALTH EFFECTS OF 
PERFLUOROALKYL OR POLYFLUOROALKYL 
SUBSTANCES. 
The Secretary of Defense shall provide to each med-
ical provider of the Department of Defense mandatory 
training with respect to the potential health effects of 
perfluoroalkyl or polyfluoroalkyl substances. 
SEC. 749. PILOT PROGRAM ON SLEEP APNEA AMONG NEW 
RECRUITS. 
(a) PILOT PROGRAM.—The Secretary of Defense, 
acting through the Defense Health Agency, shall carry out 
a pilot program to determine the prevalence of sleep apnea 
among members of the Armed Forces assigned to initial 
training. 
(b) PARTICIPATION.— 
(1) MEMBERS.—The Secretary shall ensure 
that the number of members who participate in the 
pilot program under subsection (a) is sufficient to 
collect statistically significant data for each military 
department. 
(2) SPECIAL
RULE.—The Secretary may not 
disqualify a member from service in the Armed
775 
Forces by reason of the member being diagnosed 
with sleep apnea pursuant to the pilot program 
under subsection (a). 
SEC. 750. SURVEY ON EFFECTS OF COVID–19 MANDATE ON 
MATTERS RELATING TO RECRUITMENT AND 
REINLISTMENT. 
(a) SURVEY.—Not later than 30 days after the date 
of the enactment of this Act, the Secretary of Defense 
shall conduct an anonymous survey to determine the ef-
fects that the COVID–19 vaccine mandate issued by the 
Secretary on August 24, 2021, has had on recruitment 
to and reenlistment in the Armed Forces. 
(b) MATTERS.—The survey under subsection (a) 
shall include an assessment of the following: 
(1) Whether the announcement of the COVID– 
19 vaccine mandate encouraged the reenlistment, 
discouraged the reenlistment, or had any effect on 
the reenlistment, of members of the Armed Forces. 
(2) Whether the announcement of the COVID– 
19 vaccine mandate encouraged individuals to join 
the Armed Forces, discouraged individuals to join 
the Armed Forces, or had any other effect on re-
cruitment efforts for the Armed Forces. 
(c) PUBLICATION AND SUBMISSION TO CONGRESS.—
776 
(1) IN
GENERAL.—Not later than 240 days 
after the date of the enactment of this Act, the Sec-
retary shall submit to Congress the results of the 
survey under subsection (a) and publish such results 
on an internet website of the Department of De-
fense. 
(2) PRIVACY CONSIDERATIONS.—In submitting 
and publishing the results of the survey under para-
graph (1), the Secretary shall ensure that such re-
sults do not include any personally identifiable infor-
mation of Armed Forces recruits, members of the 
Armed Forces, or any other individual surveyed 
under this section. 
SEC. 751. FUNDING FOR PANCREATIC CANCER RESEARCH. 
(a) INCREASE.—Notwithstanding the amounts set 
forth in the funding tables in division D, the amount au-
thorized to be appropriated in section 1405 for the De-
fense Health Program, as specified in the corresponding 
funding table in section 4501, for R&D Research is hereby 
increased by $5,000,000 for the purposes of pancreatic 
cancer research, of which $5,000,000 is for the purposes 
of a pancreatic cancer early detection initiative (EDI). 
(b) OFFSET.—Notwithstanding the amounts set forth 
in the funding tables in division D, the amount authorized 
to be appropriated in section 1405 for Defense Health
777 
Program, as specified in the corresponding funding table 
in section 4501, for Base Operations/Communications is 
hereby reduced by $5,000,000. 
SEC. 752. REPORT ON DISCREPANCIES BETWEEN TRICARE 
PROGRAM AND CHAMPVA PROGRAM IN CER-
TAIN COVERAGE STANDARDS. 
(a) REPORT.—Not later than 180 days after the date 
of the enactment of this Act, the Secretary of Defense 
shall submit to Congress a report that details any discrep-
ancies between the TRICARE program and the 
CHAMPVA program of the Department of Veterans Af-
fairs, with respect to coverage standards under such pro-
grams for nursing home care and in-home care. 
(b) MATTERS.—The report under subsection (a) shall 
include, with respect to any standard described in such 
subsection under the TRICARE program that the Sec-
retary determines is lower than the corresponding stand-
ard under the CHAMPVA program of the Department of 
Veterans Affairs, a description of— 
(1) the anticipated cost of aligning such lower 
standard to conform with the higher standard; and 
(2) any obstacles (including statutory, regu-
latory, or other obstacles) to such alignment.
778 
SEC. 753. FUNDING FOR RAPID SCREENING UNDER DEVEL-
OPMENT OF MEDICAL COUNTERMEASURES 
AGAINST NOVEL ENTITIES PROGRAM. 
(a) INCREASE.—Notwithstanding the amounts set 
forth in the funding tables in division D, the amount au-
thorized to be appropriated in section 4201 for Advanced 
Component Development & Prototypes, Research, Devel-
opment, Test, and Evaluation, Defense-Wide, as specified 
in the corresponding funding table in section 4201, for 
the Chemical and Biological Defense Program- DEM/ 
VAL, Line 82, is hereby increased by $4,500,000 for the 
Development of Medical Countermeasures Against Novel 
Entities program of the Defense Threat Reduction Agen-
cy, to allow for the rapid screening of all compounds ap-
proved by the Food and Drug Administration, and other 
human-safe compound libraries, to identify optimal drug 
candidates for repurposing as medical countermeasures 
for COVID–19 and other novel and emerging biological 
threats. 
(b) OFFSET.—Notwithstanding the amounts set forth 
in the funding tables in division D, the amount authorized 
to be appropriated in section 4201 for Operations and 
Maintenance, Defense-Wide, as specified in the cor-
responding funding table in 4301, for Defense Media Ac-
tivity, Line 370, is hereby reduced by $4,500,000.
779 
SEC. 754. INCREASED COLLABORATION WITH NIH TO COM-
BAT TRIPLE NEGATIVE BREAST CANCER. 
(a) IN GENERAL.—The Office of Health of the De-
partment of Defense shall work in collaboration with the 
National Institutes of Health to— 
(1) identify specific genetic and molecular tar-
gets and biomarkers for triple negative breast can-
cer; and 
(2) provide information useful in biomarker se-
lection, drug discovery, and clinical trials design that 
will enable both— 
(A) triple negative breast cancer patients 
to be identified earlier in the progression of 
their disease; and 
(B) the development of multiple targeted 
therapies for the disease. 
(b) FUNDING.—Notwithstanding the amounts set 
forth in the funding tables in division D, the amount au-
thorized to be appropriated by section 1405 for the De-
fense Health Program, as specified in the corresponding 
funding tables in division D, is hereby increased by 
$10,000,000 to carry out subsection (a). 
(c) OFFSET.—Notwithstanding the amounts set forth 
in the funding tables in division D, the amount authorized 
to be appropriated by section 1405 for the Defense Health 
Program, as specified in the corresponding funding tables
780 
in division D, for Private Sector Care is hereby reduced 
by $10,000,000. 
SEC. 755. FUNDING FOR POST-TRAUMATIC STRESS DIS-
ORDER. 
(a) FUNDING.—Notwithstanding the amounts set 
forth in the funding tables in division D, the amount au-
thorized to be appropriated by section 1405 for the De-
fense Health Program, as specified in the corresponding 
funding table in such division, is hereby increased by 
$2,500,000 for post-traumatic stress disorder. 
(b) OFFSET.—Notwithstanding the amounts set forth 
in the funding tables in division D, the amount authorized 
to be appropriated by section 1405 for the Defense Health 
Program, as specified in the corresponding funding tables 
in division D, for Private Sector Care is hereby reduced 
by $2,500,000. 
SEC. 756. REPORT ON RATE OF MATERNAL MORTALITY 
AMONG MEMBERS OF THE ARMED FORCES. 
Not later than 180 days after the date of the enact-
ment of this Act, the Secretary of Defense, and with re-
spect to members of the Coast Guard, the Secretary of 
the Department in which the Coast Guard is operating 
when it is not operating as a service in the Navy, shall 
submit to Congress a report on the rate of maternal mor-
781 
tality among members of the Armed Forces and the de-
pendents of such members. 
SEC. 757. SENSE OF CONGRESS ON DESIGNATION OF MILI-
TARY HEART HEALTH AWARENESS DAY. 
It is the sense of Congress that there should be des-
ignated a ‘‘Military Heart Health Awareness Day’’. 
SEC. 758. PILOT PROGRAM TO IMPROVE MILITARY READI-
NESS THROUGH NUTRITION AND WELLNESS 
INITIATIVES. 
(a) PILOT PROGRAM.—The Secretary of Defense, in 
consultation with the Secretaries of the military depart-
ments, shall carry out a pilot program to improve military 
readiness through nutrition and wellness initiatives. 
(b) UNIT SELECTION.—The Secretary of Defense 
shall select for participation in the pilot program under 
subsection (a) a unit at a basic training facility or an early 
instructional facility of a military department. 
(c) ELEMENTS.—The pilot program under subsection 
(a) shall include the following activities: 
(1) The development, and administration to the 
unit selected pursuant to subsection (b), of an edu-
cational curriculum relating to nutrition, physical 
fitness, the proper use of supplements, and any 
other human performance elements determined rel-
783 
etary supplements to be provided pursuant to 
subsection (c)(3). 
(B) Whether the manufacturing facility of 
the contractor is a fully independent, third- 
party certified, manufacturing facility that 
holds the highest ‘‘Good Manufacturing Prac-
tice’’ certification or rating possible, as issued 
by a regulatory agency of the Federal govern-
ment. 
(C) Whether the manufacturing facility of 
the contractor, and all finished products manu-
factured therein, have been verified by a third- 
party as free from banned substances and con-
taminants. 
(D) Whether the contractor is in compli-
ance with the adverse event reporting policy 
and third-party adverse event monitoring policy 
of the Food and Drug Administration. 
(E) Whether the contractor implements a 
stability testing program that supports product 
expiration dating. 
(F) Whether the contractor has a credible 
and robust environment, social, and governance 
policy that articulates responsibilities and an-
nual goals.
784 
(G) Whether the contractor has dem-
onstrated at least five years of operation as a 
business in good standing in the industry. 
(H) Whether the contractor has a dem-
onstrated history of maintaining relationships 
with nationally-recognized medical and health 
organizations. 
(e) COORDINATION.—In carrying out the pilot pro-
gram under subsection (a), the contractor selected under 
subsection (d) shall coordinate with the following: 
(1) Command, training, and medical officers 
and noncommissioned officers. 
(2) Outside experts (including experts with rel-
evant experience from research and testing organiza-
tions, credible medical committees, or hospitals) that 
may lend personalized support, capture data, and fa-
cilitate third-party adverse event reporting. 
(f) DURATION.—The pilot program under subsection 
(a) shall be for a period of six months. 
(g) REPORT.—Upon the termination of the pilot pro-
gram under subsection (a), the Secretary of Defense shall 
submit to the congressional defense committees a report 
on the results of the pilot program, including any findings 
or data from the pilot program, and a recommendation 
by the Secretary of Defense for improvements to the readi-
785 
ness of the Armed Forces based on such findings and 
data. 
SEC. 759. MANDATORY TRAINING ON TREATMENT OF EAT-
ING DISORDERS. 
The Secretary of Defense shall furnish to each med-
ical professional who provides direct care services under 
the military health system a mandatory training, con-
sistent with generally accepted standards of care, on how 
to screen, intervene, and refer patients to treatment, for 
the severe mental illness of eating disorders. 
SEC. 760. PRIORITY FOR DOMESTICALLY SOURCED BOVINE 
HEPARIN. 
The Secretary of Defense shall provide priority for 
domestically sourced, fully traceable, bovine heparin ap-
proved by the Food and Drug Administration when avail-
able. 
SEC. 761. ACCESS TO MENSTRUAL HYGIENE PRODUCTS 
AND ACCOMMODATIONS. 
Not later than 180 days after the date of enactment 
of this Act, the Secretary of Defense shall submit to Con-
gress a report on the availability of menstrual hygiene 
products on military bases, and accommodations related 
to menstrual hygiene available to members of the Armed 
Forces.
786 
SEC. 762. REPORT ON PRECONCEPTION AND PRENATAL 
CARRIER 
SCREENING 
TESTS 
UNDER 
TRICARE. 
(a) IN GENERAL.—Not later than 180 days after the 
date of enactment of this Act, the Secretary of Defense 
shall submit to Congress a report on potential TRICARE 
coverage of preconception and prenatal carrier screening 
tests for certain medical conditions. 
(b) REPORT CONTENTS.—The report required under 
subsection (a) shall include, with respect to such tests— 
(1) a cost-benefit analysis of TRICARE cov-
erage expansion; 
(2) an assessment of the coverage of such tests 
by public and private sector health plans; and 
(3) an assessment of the benefits to health out-
comes for military families and the impact, if any, 
on military readiness of members of the Armed 
Forces. 
(c) DEFINITION OF TRICARE.—In this section, the 
term ‘‘TRICARE’’ has the meaning given that term in 
section 1072 of title 10, United States Code.
787 
TITLE VIII—ACQUISITION POL-
ICY, ACQUISITION MANAGE-
MENT, AND RELATED MAT-
TERS 
Subtitle A—Acquisition Policy and 
Management 
SEC. 801. ACQUISITION WORKFORCE EDUCATIONAL PART-
NERSHIPS. 
(a) IN GENERAL.—Subchapter IV of chapter 87 of 
title 10, United States Code, is amended by inserting after 
section 1746 the following new section: 
‘‘§ 1746a. Acquisition workforce educational partner-
ships 
‘‘(a) ESTABLISHMENT.—The Secretary of Defense, 
acting through the Under Secretary of Defense for Acqui-
sition and Sustainment, shall establish a program within 
Defense Acquisition University to— 
‘‘(1) facilitate the engagement of experts in in-
structional design from participants in the acquisi-
tion research organization established under section 
2361a with the faculty of the Defense Acquisition 
University to organize and adjust the curriculum of 
the Defense Acquisition University, as appropriate, 
to ensure that—
788 
‘‘(A) the curriculum accords with the edu-
cational 
framework 
commonly 
known 
as 
Bloom’s taxonomy; 
‘‘(B) classes are composed of students 
from diverse positions in the acquisition work-
force; and 
‘‘(C) higher level classes require students 
to create solutions to operational challenges re-
lated to acquisition policy reform through 
human-centered design projects; 
‘‘(2) in coordination with the Office of Human 
Capital Initiatives, facilitate the retention of critical 
members of the acquisition workforce by providing 
academic advising with respect to classes offered by 
the Defense Acquisition University to both members 
of the acquisition workforce and the supervisors of 
the members to ensure that each member takes the 
classes that are suited to the experience level, posi-
tion, and professional development of such member; 
‘‘(3) partner with extramural institutions to 
offer training to all members of the acquisition 
workforce addressing operational challenges that af-
fect procurement decision-making, including training 
on—